Global and Japan Drugs for Rheumatoid Arthritis Market Insights, Forecast to 2026
Table of Contents1 Study Coverage
1.1 Drugs for Rheumatoid Arthritis Product Introduction
1.2 Market Segments
1.3 Key Drugs for Rheumatoid Arthritis Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Drugs for Rheumatoid Arthritis Market Size Growth Rate by Type
1.4.2 Prescription
1.4.3 OTC
1.5 Market by Application
1.5.1 Global Drugs for Rheumatoid Arthritis Market Size Growth Rate by Application
1.5.2 Hospital
1.5.3 Clinics
1.5.4 Other
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Drugs for Rheumatoid Arthritis Market Size, Estimates and Forecasts
2.1.1 Global Drugs for Rheumatoid Arthritis Revenue 2015-2026
2.1.2 Global Drugs for Rheumatoid Arthritis Sales 2015-2026
2.2 Global Drugs for Rheumatoid Arthritis, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.3 Drugs for Rheumatoid Arthritis Historical Market Size by Region (2015-2020)
2.3.1 Global Drugs for Rheumatoid Arthritis Retrospective Market Scenario in Sales by Region: 2015-2020
2.3.2 Global Drugs for Rheumatoid Arthritis Retrospective Market Scenario in Revenue by Region: 2015-2020
2.4 Drugs for Rheumatoid Arthritis Market Estimates and Projections by Region (2021-2026)
2.4.1 Global Drugs for Rheumatoid Arthritis Sales Forecast by Region (2021-2026)
2.4.2 Global Drugs for Rheumatoid Arthritis Revenue Forecast by Region (2021-2026)
3 Global Drugs for Rheumatoid Arthritis Competitor Landscape by Players
3.1 Global Top Drugs for Rheumatoid Arthritis Sales by Manufacturers
3.1.1 Global Drugs for Rheumatoid Arthritis Sales by Manufacturers (2015-2020)
3.1.2 Global Drugs for Rheumatoid Arthritis Sales Market Share by Manufacturers (2015-2020)
3.2 Global Drugs for Rheumatoid Arthritis Manufacturers by Revenue
3.2.1 Global Drugs for Rheumatoid Arthritis Revenue by Manufacturers (2015-2020)
3.2.2 Global Drugs for Rheumatoid Arthritis Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Drugs for Rheumatoid Arthritis Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Drugs for Rheumatoid Arthritis Revenue in 2019
3.2.5 Global Drugs for Rheumatoid Arthritis Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Drugs for Rheumatoid Arthritis Price by Manufacturers
3.4 Global Drugs for Rheumatoid Arthritis Manufacturing Base Distribution, Product Types
3.4.1 Drugs for Rheumatoid Arthritis Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Drugs for Rheumatoid Arthritis Product Type
3.4.3 Date of International Manufacturers Enter into Drugs for Rheumatoid Arthritis Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Drugs for Rheumatoid Arthritis Market Size by Type (2015-2020)
4.1.1 Global Drugs for Rheumatoid Arthritis Sales by Type (2015-2020)
4.1.2 Global Drugs for Rheumatoid Arthritis Revenue by Type (2015-2020)
4.1.3 Drugs for Rheumatoid Arthritis Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Drugs for Rheumatoid Arthritis Market Size Forecast by Type (2021-2026)
4.2.1 Global Drugs for Rheumatoid Arthritis Sales Forecast by Type (2021-2026)
4.2.2 Global Drugs for Rheumatoid Arthritis Revenue Forecast by Type (2021-2026)
4.2.3 Drugs for Rheumatoid Arthritis Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Drugs for Rheumatoid Arthritis Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Drugs for Rheumatoid Arthritis Market Size by Application (2015-2020)
5.1.1 Global Drugs for Rheumatoid Arthritis Sales by Application (2015-2020)
5.1.2 Global Drugs for Rheumatoid Arthritis Revenue by Application (2015-2020)
5.1.3 Drugs for Rheumatoid Arthritis Price by Application (2015-2020)
5.2 Drugs for Rheumatoid Arthritis Market Size Forecast by Application (2021-2026)
5.2.1 Global Drugs for Rheumatoid Arthritis Sales Forecast by Application (2021-2026)
5.2.2 Global Drugs for Rheumatoid Arthritis Revenue Forecast by Application (2021-2026)
5.2.3 Global Drugs for Rheumatoid Arthritis Price Forecast by Application (2021-2026)
6 Japan by Players, Type and Application
6.1 Japan Drugs for Rheumatoid Arthritis Market Size YoY Growth 2015-2026
6.1.1 Japan Drugs for Rheumatoid Arthritis Sales YoY Growth 2015-2026
6.1.2 Japan Drugs for Rheumatoid Arthritis Revenue YoY Growth 2015-2026
6.1.3 Japan Drugs for Rheumatoid Arthritis Market Share in Global Market 2015-2026
6.2 Japan Drugs for Rheumatoid Arthritis Market Size by Players (International and Local Players)
6.2.1 Japan Top Drugs for Rheumatoid Arthritis Players by Sales (2015-2020)
6.2.2 Japan Top Drugs for Rheumatoid Arthritis Players by Revenue (2015-2020)
6.3 Japan Drugs for Rheumatoid Arthritis Historic Market Review by Type (2015-2020)
6.3.1 Japan Drugs for Rheumatoid Arthritis Sales Market Share by Type (2015-2020)
6.3.2 Japan Drugs for Rheumatoid Arthritis Revenue Market Share by Type (2015-2020)
6.3.3 Japan Drugs for Rheumatoid Arthritis Price by Type (2015-2020)
6.4 Japan Drugs for Rheumatoid Arthritis Market Estimates and Forecasts by Type (2021-2026)
6.4.1 Japan Drugs for Rheumatoid Arthritis Sales Forecast by Type (2021-2026)
6.4.2 Japan Drugs for Rheumatoid Arthritis Revenue Forecast by Type (2021-2026)
6.4.3 Japan Drugs for Rheumatoid Arthritis Price Forecast by Type (2021-2026)
6.5 Japan Drugs for Rheumatoid Arthritis Historic Market Review by Application (2015-2020)
6.5.1 Japan Drugs for Rheumatoid Arthritis Sales Market Share by Application (2015-2020)
6.5.2 Japan Drugs for Rheumatoid Arthritis Revenue Market Share by Application (2015-2020)
6.5.3 Japan Drugs for Rheumatoid Arthritis Price by Application (2015-2020)
6.6 Japan Drugs for Rheumatoid Arthritis Market Estimates and Forecasts by Application (2021-2026)
6.6.1 Japan Drugs for Rheumatoid Arthritis Sales Forecast by Application (2021-2026)
6.6.2 Japan Drugs for Rheumatoid Arthritis Revenue Forecast by Application (2021-2026)
6.6.3 Japan Drugs for Rheumatoid Arthritis Price Forecast by Application (2021-2026)
7 North America
7.1 North America Drugs for Rheumatoid Arthritis Market Size YoY Growth 2015-2026
7.2 North America Drugs for Rheumatoid Arthritis Market Facts & Figures by Country
7.2.1 North America Drugs for Rheumatoid Arthritis Sales by Country (2015-2020)
7.2.2 North America Drugs for Rheumatoid Arthritis Revenue by Country (2015-2020)
7.2.3 U.S.
7.2.4 Canada
8 Europe
8.1 Europe Drugs for Rheumatoid Arthritis Market Size YoY Growth 2015-2026
8.2 Europe Drugs for Rheumatoid Arthritis Market Facts & Figures by Country
8.2.1 Europe Drugs for Rheumatoid Arthritis Sales by Country
8.2.2 Europe Drugs for Rheumatoid Arthritis Revenue by Country
8.2.3 Germany
8.2.4 France
8.2.5 U.K.
8.2.6 Italy
8.2.7 Russia
9 Asia Pacific
9.1 Asia Pacific Drugs for Rheumatoid Arthritis Market Size YoY Growth 2015-2026
9.2 Asia Pacific Drugs for Rheumatoid Arthritis Market Facts & Figures by Country
9.2.1 Asia Pacific Drugs for Rheumatoid Arthritis Sales by Region (2015-2020)
9.2.2 Asia Pacific Drugs for Rheumatoid Arthritis Revenue by Region
9.2.3 China
9.2.4 Japan
9.2.5 South Korea
9.2.6 India
9.2.7 Australia
9.2.8 Taiwan
9.2.9 Indonesia
9.2.10 Thailand
9.2.11 Malaysia
9.2.12 Philippines
9.2.13 Vietnam
10 Latin America
10.1 Latin America Drugs for Rheumatoid Arthritis Market Size YoY Growth 2015-2026
10.2 Latin America Drugs for Rheumatoid Arthritis Market Facts & Figures by Country
10.2.1 Latin America Drugs for Rheumatoid Arthritis Sales by Country
10.2.2 Latin America Drugs for Rheumatoid Arthritis Revenue by Country
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Drugs for Rheumatoid Arthritis Market Size YoY Growth 2015-2026
11.2 Middle East and Africa Drugs for Rheumatoid Arthritis Market Facts & Figures by Country
11.2.1 Middle East and Africa Drugs for Rheumatoid Arthritis Sales by Country
11.2.2 Middle East and Africa Drugs for Rheumatoid Arthritis Revenue by Country
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 U.A.E
12 Company Profiles
12.1 AbbVie Inc
12.1.1 AbbVie Inc Corporation Information
12.1.2 AbbVie Inc Description and Business Overview
12.1.3 AbbVie Inc Sales, Revenue and Gross Margin (2015-2020)
12.1.4 AbbVie Inc Drugs for Rheumatoid Arthritis Products Offered
12.1.5 AbbVie Inc Recent Development
12.2 Hoffman-La Roche AG
12.2.1 Hoffman-La Roche AG Corporation Information
12.2.2 Hoffman-La Roche AG Description and Business Overview
12.2.3 Hoffman-La Roche AG Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Hoffman-La Roche AG Drugs for Rheumatoid Arthritis Products Offered
12.2.5 Hoffman-La Roche AG Recent Development
12.3 Amgen Inc
12.3.1 Amgen Inc Corporation Information
12.3.2 Amgen Inc Description and Business Overview
12.3.3 Amgen Inc Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Amgen Inc Drugs for Rheumatoid Arthritis Products Offered
12.3.5 Amgen Inc Recent Development
12.4 Pfizer Inc
12.4.1 Pfizer Inc Corporation Information
12.4.2 Pfizer Inc Description and Business Overview
12.4.3 Pfizer Inc Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Pfizer Inc Drugs for Rheumatoid Arthritis Products Offered
12.4.5 Pfizer Inc Recent Development
12.5 Bristol-Myers Squibb Co
12.5.1 Bristol-Myers Squibb Co Corporation Information
12.5.2 Bristol-Myers Squibb Co Description and Business Overview
12.5.3 Bristol-Myers Squibb Co Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Bristol-Myers Squibb Co Drugs for Rheumatoid Arthritis Products Offered
12.5.5 Bristol-Myers Squibb Co Recent Development
12.6 Johnson & Johnson
12.6.1 Johnson & Johnson Corporation Information
12.6.2 Johnson & Johnson Description and Business Overview
12.6.3 Johnson & Johnson Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Johnson & Johnson Drugs for Rheumatoid Arthritis Products Offered
12.6.5 Johnson & Johnson Recent Development
12.7 UCB Biosciences Inc
12.7.1 UCB Biosciences Inc Corporation Information
12.7.2 UCB Biosciences Inc Description and Business Overview
12.7.3 UCB Biosciences Inc Sales, Revenue and Gross Margin (2015-2020)
12.7.4 UCB Biosciences Inc Drugs for Rheumatoid Arthritis Products Offered
12.7.5 UCB Biosciences Inc Recent Development
12.8 Mitsubishi Tanabe Pharma Corp
12.8.1 Mitsubishi Tanabe Pharma Corp Corporation Information
12.8.2 Mitsubishi Tanabe Pharma Corp Description and Business Overview
12.8.3 Mitsubishi Tanabe Pharma Corp Sales, Revenue and Gross Margin (2015-2020)
12.8.4 Mitsubishi Tanabe Pharma Corp Drugs for Rheumatoid Arthritis Products Offered
12.8.5 Mitsubishi Tanabe Pharma Corp Recent Development
12.9 Biogen Inc
12.9.1 Biogen Inc Corporation Information
12.9.2 Biogen Inc Description and Business Overview
12.9.3 Biogen Inc Sales, Revenue and Gross Margin (2015-2020)
12.9.4 Biogen Inc Drugs for Rheumatoid Arthritis Products Offered
12.9.5 Biogen Inc Recent Development
12.10 Merck & Co
12.10.1 Merck & Co Corporation Information
12.10.2 Merck & Co Description and Business Overview
12.10.3 Merck & Co Sales, Revenue and Gross Margin (2015-2020)
12.10.4 Merck & Co Drugs for Rheumatoid Arthritis Products Offered
12.10.5 Merck & Co Recent Development
12.11 AbbVie Inc
12.11.1 AbbVie Inc Corporation Information
12.11.2 AbbVie Inc Description and Business Overview
12.11.3 AbbVie Inc Sales, Revenue and Gross Margin (2015-2020)
12.11.4 AbbVie Inc Drugs for Rheumatoid Arthritis Products Offered
12.11.5 AbbVie Inc Recent Development
12.12 Pharmaceuticals
12.12.1 Pharmaceuticals Corporation Information
12.12.2 Pharmaceuticals Description and Business Overview
12.12.3 Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
12.12.4 Pharmaceuticals Products Offered
12.12.5 Pharmaceuticals Recent Development
12.13 Biopharmaceuticals
12.13.1 Biopharmaceuticals Corporation Information
12.13.2 Biopharmaceuticals Description and Business Overview
12.13.3 Biopharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
12.13.4 Biopharmaceuticals Products Offered
12.13.5 Biopharmaceuticals Recent Development
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter's Five Forces Analysis
13.5 Primary Interviews with Key Drugs for Rheumatoid Arthritis Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Drugs for Rheumatoid Arthritis Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of TablesTable 1. Drugs for Rheumatoid Arthritis Market Segments
Table 2. Ranking of Global Top Drugs for Rheumatoid Arthritis Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Drugs for Rheumatoid Arthritis Market Size Growth Rate by Type 2020-2026 (K Units) & (US$ Million)
Table 4. Major Manufacturers of Prescription
Table 5. Major Manufacturers of OTC
Table 6. Global Drugs for Rheumatoid Arthritis Market Size Growth Rate by Application 2020-2026 (K Units)
Table 7. Global Drugs for Rheumatoid Arthritis Market Size by Region (K Units) & (US$ Million): 2020 VS 2026
Table 8. Global Drugs for Rheumatoid Arthritis Sales by Regions 2015-2020 (K Units)
Table 9. Global Drugs for Rheumatoid Arthritis Sales Market Share by Regions (2015-2020)
Table 10. Global Drugs for Rheumatoid Arthritis Revenue by Regions 2015-2020 (US$ Million)
Table 11. Global Drugs for Rheumatoid Arthritis Sales Forecast by Region (2021-2026) (K Units)
Table 12. Global Drugs for Rheumatoid Arthritis Sales by Manufacturers (2015-2020) (K Units)
Table 13. Global Drugs for Rheumatoid Arthritis Sales Share by Manufacturers (2015-2020)
Table 14. Global Drugs for Rheumatoid Arthritis Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 15. Global Drugs for Rheumatoid Arthritis by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Drugs for Rheumatoid Arthritis as of 2019)
Table 16. Drugs for Rheumatoid Arthritis Revenue by Manufacturers (2015-2020) (US$ Million)
Table 17. Drugs for Rheumatoid Arthritis Revenue Share by Manufacturers (2015-2020)
Table 18. Key Manufacturers Drugs for Rheumatoid Arthritis Price (2015-2020) (USD/Unit)
Table 19. Drugs for Rheumatoid Arthritis Manufacturers Manufacturing Base Distribution and Headquarters
Table 20. Manufacturers Drugs for Rheumatoid Arthritis Product Type
Table 21. Date of International Manufacturers Enter into Drugs for Rheumatoid Arthritis Market
Table 22. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 23. Global Drugs for Rheumatoid Arthritis Sales by Type (2015-2020) (K Units)
Table 24. Global Drugs for Rheumatoid Arthritis Sales Share by Type (2015-2020)
Table 25. Global Drugs for Rheumatoid Arthritis Revenue by Type (2015-2020) (US$ Million)
Table 26. Global Drugs for Rheumatoid Arthritis Revenue Share by Type (2015-2020)
Table 27. Drugs for Rheumatoid Arthritis Average Selling Price (ASP) by Type 2015-2020 (USD/Unit)
Table 28. Global Drugs for Rheumatoid Arthritis Sales Share by Type (2021-2026)
Table 29. Global Drugs for Rheumatoid Arthritis Sales by Application (2015-2020) (K Units)
Table 30. Global Drugs for Rheumatoid Arthritis Sales Share by Application (2015-2020)
Table 31. Global Drugs for Rheumatoid Arthritis Sales Share by Application (2021-2026)
Table 32. Global Drugs for Rheumatoid Arthritis Sales Market Share Forecast by Application (2021-2026)
Table 33. Global Drugs for Rheumatoid Arthritis Revenue by Application (2015-2020) (US$ Million)
Table 34. Global Drugs for Rheumatoid Arthritis Revenue Market Share Forecast by Application (2021-2026)
Table 35. Japan Drugs for Rheumatoid Arthritis Sales (K Units) of Key Companies (2015-2020)
Table 36. Japan Drugs for Rheumatoid Arthritis Sales Share by Company (2015-2020)
Table 37. Japan Drugs for Rheumatoid Arthritis Revenue (US$ Million) by Company (2015-2020)
Table 38. Japan Drugs for Rheumatoid Arthritis Sales (K Units) by Type (2015-2020)
Table 39. Japan Drugs for Rheumatoid Arthritis Sales Share by Type (2015-2020)
Table 40. Japan Drugs for Rheumatoid Arthritis Revenue (US$ Million) Market Share by Type (2015-2020)
Table 41. Japan Drugs for Rheumatoid Arthritis Price (K Units) by Type (2015-2020)
Table 42. Japan Drugs for Rheumatoid Arthritis Sales (K Units) by Type (2021-2026)
Table 43. Japan Drugs for Rheumatoid Arthritis Sales Share by Type (2021-2026)
Table 44. Japan Drugs for Rheumatoid Arthritis Revenue (US$ Million) Market Share by Type (2021-2026)
Table 45. Japan Drugs for Rheumatoid Arthritis Revenue Share by Type (2021-2026)
Table 46. Japan Drugs for Rheumatoid Arthritis Price (K Units) by Type (2021-2026)
Table 47. Japan Drugs for Rheumatoid Arthritis Sales (K Units) by Application (2015-2020)
Table 48. Japan Drugs for Rheumatoid Arthritis Sales Share by Application (2015-2020)
Table 49. Japan Drugs for Rheumatoid Arthritis Revenue (US$ Million) Market Share by Application (2015-2020)
Table 50. Japan Drugs for Rheumatoid Arthritis Sales (K Units) by Application (2021-2026)
Table 51. Japan Drugs for Rheumatoid Arthritis Sales Share by Application (2021-2026)
Table 52. Japan Drugs for Rheumatoid Arthritis Revenue (US$ Million) Market Share by Application (2021-2026)
Table 53. Japan Drugs for Rheumatoid Arthritis Revenue Share by Application (2021-2026)
Table 54. North America Drugs for Rheumatoid Arthritis Sales by Country (2015-2020) (K Units)
Table 55. North America Drugs for Rheumatoid Arthritis Sales Market Share by Country (2015-2020)
Table 56. North America Drugs for Rheumatoid Arthritis Revenue by Country (2015-2020) (US$ Million)
Table 57. North America Drugs for Rheumatoid Arthritis Revenue Market Share by Country (2015-2020)
Table 58. Europe Drugs for Rheumatoid Arthritis Sales by Country (2015-2020) (K Units)
Table 59. Europe Drugs for Rheumatoid Arthritis Sales Market Share by Country (2015-2020)
Table 60. Europe Drugs for Rheumatoid Arthritis Revenue by Country (2015-2020) (US$ Million)
Table 61. Europe Drugs for Rheumatoid Arthritis Revenue Market Share by Country (2015-2020)
Table 62. Asia Pacific Drugs for Rheumatoid Arthritis Sales by Region (2015-2020) (K Units)
Table 63. Asia Pacific Drugs for Rheumatoid Arthritis Sales Market Share by Region (2015-2020)
Table 64. Asia Pacific Drugs for Rheumatoid Arthritis Revenue by Region (2015-2020) (US$ Million)
Table 65. Asia Pacific Drugs for Rheumatoid Arthritis Revenue Market Share by Region (2015-2020)
Table 66. Latin America Drugs for Rheumatoid Arthritis Sales by Country (2015-2020) (K Units)
Table 67. Latin America Drugs for Rheumatoid Arthritis Sales Market Share by Country (2015-2020)
Table 68. Latin Americaa Drugs for Rheumatoid Arthritis Revenue by Country (2015-2020) (US$ Million)
Table 69. Latin America Drugs for Rheumatoid Arthritis Revenue Market Share by Country (2015-2020)
Table 70. Middle East and Africa Drugs for Rheumatoid Arthritis Sales by Country (2015-2020) (K Units)
Table 71. Middle East and Africa Drugs for Rheumatoid Arthritis Sales Market Share by Country (2015-2020)
Table 72. Middle East and Africa Drugs for Rheumatoid Arthritis Revenue by Country (2015-2020) (US$ Million)
Table 73. Middle East and Africa Drugs for Rheumatoid Arthritis Revenue Market Share by Country (2015-2020)
Table 74. AbbVie Inc Corporation Information
Table 75. AbbVie Inc Description and Business Overview
Table 76. AbbVie Inc Drugs for Rheumatoid Arthritis Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 77. AbbVie Inc Drugs for Rheumatoid Arthritis Product
Table 78. AbbVie Inc Recent Development
Table 79. Hoffman-La Roche AG Corporation Information
Table 80. Hoffman-La Roche AG Description and Business Overview
Table 81. Hoffman-La Roche AG Drugs for Rheumatoid Arthritis Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 82. Hoffman-La Roche AG Product
Table 83. Hoffman-La Roche AG Recent Development
Table 84. Amgen Inc Corporation Information
Table 85. Amgen Inc Description and Business Overview
Table 86. Amgen Inc Drugs for Rheumatoid Arthritis Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 87. Amgen Inc Product
Table 88. Amgen Inc Recent Development
Table 89. Pfizer Inc Corporation Information
Table 90. Pfizer Inc Description and Business Overview
Table 91. Pfizer Inc Drugs for Rheumatoid Arthritis Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 92. Pfizer Inc Product
Table 93. Pfizer Inc Recent Development
Table 94. Bristol-Myers Squibb Co Corporation Information
Table 95. Bristol-Myers Squibb Co Description and Business Overview
Table 96. Bristol-Myers Squibb Co Drugs for Rheumatoid Arthritis Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 97. Bristol-Myers Squibb Co Product
Table 98. Bristol-Myers Squibb Co Recent Development
Table 99. Johnson & Johnson Corporation Information
Table 100. Johnson & Johnson Description and Business Overview
Table 101. Johnson & Johnson Drugs for Rheumatoid Arthritis Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 102. Johnson & Johnson Product
Table 103. Johnson & Johnson Recent Development
Table 104. UCB Biosciences Inc Corporation Information
Table 105. UCB Biosciences Inc Description and Business Overview
Table 106. UCB Biosciences Inc Drugs for Rheumatoid Arthritis Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 107. UCB Biosciences Inc Product
Table 108. UCB Biosciences Inc Recent Development
Table 109. Mitsubishi Tanabe Pharma Corp Corporation Information
Table 110. Mitsubishi Tanabe Pharma Corp Description and Business Overview
Table 111. Mitsubishi Tanabe Pharma Corp Drugs for Rheumatoid Arthritis Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 112. Mitsubishi Tanabe Pharma Corp Product
Table 113. Mitsubishi Tanabe Pharma Corp Recent Development
Table 114. Biogen Inc Corporation Information
Table 115. Biogen Inc Description and Business Overview
Table 116. Biogen Inc Drugs for Rheumatoid Arthritis Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 117. Biogen Inc Product
Table 118. Biogen Inc Recent Development
Table 119. Merck & Co Corporation Information
Table 120. Merck & Co Description and Business Overview
Table 121. Merck & Co Drugs for Rheumatoid Arthritis Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 122. Merck & Co Product
Table 123. Merck & Co Recent Development
Table 124. Market Segment by Product Type Corporation Information
Table 125. Market Segment by Product Type Description and Business Overview
Table 126. Market Segment by Product Type Drugs for Rheumatoid Arthritis Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 127. Market Segment by Product Type Product
Table 128. Market Segment by Product Type Recent Development
Table 129. Pharmaceuticals Corporation Information
Table 130. Pharmaceuticals Description and Business Overview
Table 131. Pharmaceuticals Drugs for Rheumatoid Arthritis Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 132. Pharmaceuticals Product
Table 133. Pharmaceuticals Recent Development
Table 134. Biopharmaceuticals Corporation Information
Table 135. Biopharmaceuticals Description and Business Overview
Table 136. Biopharmaceuticals Drugs for Rheumatoid Arthritis Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 137. Biopharmaceuticals Product
Table 138. Biopharmaceuticals Recent Development
Table 139. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 140. Key Challenges
Table 141. Market Risks
Table 142. Main Points Interviewed from Key Drugs for Rheumatoid Arthritis Players
Table 143. Drugs for Rheumatoid Arthritis Customers List
Table 144. Drugs for Rheumatoid Arthritis Distributors List
Table 145. Research Programs/Design for This Report
Table 146. Key Data Information from Secondary Sources
Table 147. Key Data Information from Primary Sources
List of FiguresFigure 1. Drugs for Rheumatoid Arthritis Product Picture
Figure 2. Global Drugs for Rheumatoid Arthritis Sales Market Share by Type in 2020 & 2026
Figure 3. Prescription Product Picture
Figure 4. OTC Product Picture
Figure 5. Global Drugs for Rheumatoid Arthritis Sales Market Share by Application in 2020 & 2026
Figure 6. Hospital
Figure 7. Clinics
Figure 8. Other
Figure 9. Drugs for Rheumatoid Arthritis Report Years Considered
Figure 10. Global Drugs for Rheumatoid Arthritis Market Size 2015-2026 (US$ Million)
Figure 11. Global Drugs for Rheumatoid Arthritis Sales 2015-2026 (K Units)
Figure 12. Global Drugs for Rheumatoid Arthritis Market Size Market Share by Region: 2020 Versus 2026
Figure 13. Global Drugs for Rheumatoid Arthritis Sales Market Share by Region (2015-2020)
Figure 14. Global Drugs for Rheumatoid Arthritis Sales Market Share by Region in 2019
Figure 15. Global Drugs for Rheumatoid Arthritis Revenue Market Share by Region (2015-2020)
Figure 16. Global Drugs for Rheumatoid Arthritis Revenue Market Share by Region in 2019
Figure 17. Global Drugs for Rheumatoid Arthritis Sales Share by Manufacturer in 2019
Figure 18. The Top 10 and 5 Players Market Share by Drugs for Rheumatoid Arthritis Revenue in 2019
Figure 19. Drugs for Rheumatoid Arthritis Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 20. Global Drugs for Rheumatoid Arthritis Sales Market Share by Type (2015-2020)
Figure 21. Global Drugs for Rheumatoid Arthritis Sales Market Share by Type in 2019
Figure 22. Global Drugs for Rheumatoid Arthritis Revenue Market Share by Type (2015-2020)
Figure 23. Global Drugs for Rheumatoid Arthritis Revenue Market Share by Type in 2019
Figure 24. Global Drugs for Rheumatoid Arthritis Market Share by Price Range (2015-2020)
Figure 25. Global Drugs for Rheumatoid Arthritis Sales Market Share by Application (2015-2020)
Figure 26. Global Drugs for Rheumatoid Arthritis Sales Market Share by Application in 2019
Figure 27. Global Drugs for Rheumatoid Arthritis Revenue Market Share by Application (2015-2020)
Figure 28. Global Drugs for Rheumatoid Arthritis Revenue Market Share by Application in 2019
Figure 29. Japan Drugs for Rheumatoid Arthritis Sales Growth Rate 2015-2026 (K Units)
Figure 30. Japan Drugs for Rheumatoid Arthritis Revenue Growth Rate 2015-2026 (US$ Million)
Figure 31. Japan Drugs for Rheumatoid Arthritis Market Share in Global Market 2015-2026
Figure 32. Japan 5 and 10 Largest Drugs for Rheumatoid Arthritis Players Market Share by Revenue in Drugs for Rheumatoid Arthritis in 2019
Figure 33. Japan Drugs for Rheumatoid Arthritis Revenue Share by Type (2015-2020)
Figure 34. Japan Drugs for Rheumatoid Arthritis Revenue Growth Rate by Type in 2015 & 2019
Figure 35. Japan Drugs for Rheumatoid Arthritis Revenue Share by Application (2015-2020)
Figure 36. Japan Drugs for Rheumatoid Arthritis Revenue Growth Rate by Application in 2015 & 2019
Figure 37. North America Drugs for Rheumatoid Arthritis Sales Growth Rate 2015-2020 (K Units)
Figure 38. North America Drugs for Rheumatoid Arthritis Revenue Growth Rate 2015-2020 (US$ Million)
Figure 39. North America Drugs for Rheumatoid Arthritis Sales Market Share by Country in 2019
Figure 40. North America Drugs for Rheumatoid Arthritis Revenue Market Share by Country in 2019
Figure 41. U.S. Drugs for Rheumatoid Arthritis Sales Growth Rate (2015-2020) (K Units)
Figure 42. U.S. Drugs for Rheumatoid Arthritis Revenue Growth Rate (2015-2020) (US$ Million)
Figure 43. Canada Drugs for Rheumatoid Arthritis Sales Growth Rate (2015-2020) (K Units)
Figure 44. Canada Drugs for Rheumatoid Arthritis Revenue Growth Rate (2015-2020) (US$ Million)
Figure 45. Europe Drugs for Rheumatoid Arthritis Sales Growth Rate 2015-2020 (K Units)
Figure 46. Europe Drugs for Rheumatoid Arthritis Revenue Growth Rate 2015-2020 (US$ Million)
Figure 47. Europe Drugs for Rheumatoid Arthritis Sales Market Share by Country in 2019
Figure 48. Europe Drugs for Rheumatoid Arthritis Revenue Market Share by Country in 2019
Figure 49. Germany Drugs for Rheumatoid Arthritis Sales Growth Rate (2015-2020) (K Units)
Figure 50. Germany Drugs for Rheumatoid Arthritis Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. France Drugs for Rheumatoid Arthritis Sales Growth Rate (2015-2020) (K Units)
Figure 52. France Drugs for Rheumatoid Arthritis Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. U.K. Drugs for Rheumatoid Arthritis Sales Growth Rate (2015-2020) (K Units)
Figure 54. U.K. Drugs for Rheumatoid Arthritis Revenue Growth Rate (2015-2020) (US$ Million)
Figure 55. Italy Drugs for Rheumatoid Arthritis Sales Growth Rate (2015-2020) (K Units)
Figure 56. Italy Drugs for Rheumatoid Arthritis Revenue Growth Rate (2015-2020) (US$ Million)
Figure 57. Russia Drugs for Rheumatoid Arthritis Sales Growth Rate (2015-2020) (K Units)
Figure 58. Russia Drugs for Rheumatoid Arthritis Revenue Growth Rate (2015-2020) (US$ Million)
Figure 59. Asia Pacific Drugs for Rheumatoid Arthritis Sales Growth Rate 2015-2020 (K Units)
Figure 60. Asia Pacific Drugs for Rheumatoid Arthritis Revenue Growth Rate 2015-2020 (US$ Million)
Figure 61. Asia Pacific Drugs for Rheumatoid Arthritis Sales Market Share by Region in 2019
Figure 62. Asia Pacific Drugs for Rheumatoid Arthritis Revenue Market Share by Region in 2019
Figure 63. China Drugs for Rheumatoid Arthritis Sales Growth Rate (2015-2020) (K Units)
Figure 64. China Drugs for Rheumatoid Arthritis Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. Japan Drugs for Rheumatoid Arthritis Sales Growth Rate (2015-2020) (K Units)
Figure 66. Japan Drugs for Rheumatoid Arthritis Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. South Korea Drugs for Rheumatoid Arthritis Sales Growth Rate (2015-2020) (K Units)
Figure 68. South Korea Drugs for Rheumatoid Arthritis Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. India Drugs for Rheumatoid Arthritis Sales Growth Rate (2015-2020) (K Units)
Figure 70. India Drugs for Rheumatoid Arthritis Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Australia Drugs for Rheumatoid Arthritis Sales Growth Rate (2015-2020) (K Units)
Figure 72. Australia Drugs for Rheumatoid Arthritis Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Taiwan Drugs for Rheumatoid Arthritis Sales Growth Rate (2015-2020) (K Units)
Figure 74. Taiwan Drugs for Rheumatoid Arthritis Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Indonesia Drugs for Rheumatoid Arthritis Sales Growth Rate (2015-2020) (K Units)
Figure 76. Indonesia Drugs for Rheumatoid Arthritis Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Thailand Drugs for Rheumatoid Arthritis Sales Growth Rate (2015-2020) (K Units)
Figure 78. Thailand Drugs for Rheumatoid Arthritis Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Malaysia Drugs for Rheumatoid Arthritis Sales Growth Rate (2015-2020) (K Units)
Figure 80. Malaysia Drugs for Rheu